About iMMCO Diagnostics
iMMCO Diagnostics is a company based in Buffalo (United States) founded in 1971 was acquired by Trinity Biotech in July 2013. The company has 78 employees as of December 31, 2022. iMMCO Diagnostics operates in a competitive market with competitors including Crescendo Bioscience, Selventa, Cytonics, DNAlytics and Augurex, among others.
- Headquarter Buffalo, United States
- Employees 78 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Immco Diagnostics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Trinity Biotech
& 1 more
-
Employee Count
78
as on Dec 31, 2022
-
Acquired by
Trinity Biotech
(Jul 26, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of iMMCO Diagnostics
Investors in iMMCO Diagnostics
iMMCO Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Trinity Biotech and Summit Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summit Partners is recognized as a growth equity investment firm.
|
Locked | Locked | Locked | |
|
Provider of In vitro diagnostic kits for clinical labs
|
Locked | Locked | Locked |
Investor details for iMMCO Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iMMCO Diagnostics
Investment portfolio details for iMMCO Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - iMMCO Diagnostics
Detailed financials for iMMCO Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immco Diagnostics Comparisons
Peer comparison for iMMCO Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iMMCO Diagnostics
iMMCO Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Crescendo Bioscience, Selventa, Cytonics, DNAlytics and Augurex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular tests for autoimmune and inflammatory diseases are provided.
|
|
| Locked | Locked | Locked |
Selventa specializes in diagnostics for personalized medicine, advancing tailored healthcare solutions.
|
|
| Locked | Locked | Locked |
Diagnostics and therapeutics for osteoarthritis are developed.
|
|
| Locked | Locked | Locked |
Data-driven personalized medicine is provided from R&D to market access.
|
|
| Locked | Locked | Locked |
Diagnostic tests for autoimmune and chronic diseases are developed.
|
Detailed competitors of iMMCO Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immco Diagnostics
Complete news archive for iMMCO Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iMMCO Diagnostics
iMMCO Diagnostics was founded in 1971 and raised its 1st funding round 36 years after it was founded.
iMMCO Diagnostics is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
As of Dec 31, 2022, the latest employee count at iMMCO Diagnostics is 78.
IMMCO Diagnostics is a provider of diagnostic solutions for autoimmune disorders. It develops and distributes autoimmune disease diagnostics devices and lab services to the market. Products include IFA ImmuGlo, Mardx, ImmuLisa, Captia (EIA), ImmuBlot, Marstripe, ImmcoStripe (line immunoassays), and Amerlex . The platform offers biopsy, serology, and other test services for the diagnosis of autoimmune disorders and related immunological conditions such as thyroiditis, rheumatoid arthritis, type 1 diabetes, coeliac disease, ulcerative colitis, Crohns disease, systemic lupus erythematosus, and scleroderma systemic sclerosis. It also provides diagnostic solutions for infectious disease, hemoglobins, autoimmune, antibodies, urinalysis, and more.
iMMCO Diagnostics's top competitors include Cytonics, Crescendo Bioscience and Augurex.
iMMCO Diagnostics has 2 investors. Key investors include Trinity Biotech, and Summit Partners.